- Aeglea BioTherapeutics (NASDAQ:AGLE) said on Tuesday it had appointed Linda Neuman as the chief medical officer.
- Neuman's appointment is an internal promotion from her previous role as Aeglea's senior vice president of clinical development.
- Before Aeglea, Neuman served as vice president, clinical development at Catalyst Biosciences where she led the clinical development of their late-stage development program for a novel hemophilia treatment.
Aeglea BioTherapeutics appoints Linda Neuman as chief medical officer
Recommended For You
More Trending News
About SYRE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SYRE | - | - |
Spyre Therapeutics, Inc. |